Latest Breaking News On - Global impression - Page 7 : comparemela.com

Subsequent to the Release of Positive Phase 3 Trial Results, Vistagen Provides Corporate Update and

Positive top-line results from Phase 3 PALISADE-2 trial of rapid-onset fasedienol (PH94B) nasal spray in social anxiety disorder (SAD)Itruvone (PH10) nasal spray now staged for Phase 2B clinical development as a stand-alone, non-systemic treatment for major depressive disorder (MDD)Positive exploratory Phase 2A tria.

United statesMark mcpartlandShawn singhExchange commissionCompany phaseCompany quarterly report on formInternational number tollDrug administrationSubjective unitsDistress scaleChief executive officerClinical global impressions improvementGlobal impressionLiebowitz social anxiety scaleNew drug applicationFiscal year

AffaMed Therapeutics Announces Partner Vistagen Reports Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder

AffaMed Therapeutics Announces Partner Vistagen Reports Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

South koreaUnited statesShawn singhDayao zhaoWellness surveyWorld mental health survey initiativeNational healthSubjective unitsDistress scaleClinical global impressions improvementAffamed therapeuticsVistagen therapeuticsChief executive officerGlobal impressionLiebowitz social anxiety scaleAmed therapeutics

VistaGen Therapeutics (VTGN) Reports Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol

VistaGen Therapeutics (VTGN) Reports Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South koreaShawn singhDayao zhaoAffamed therapeuticsVistagen therapeuticsChief executive officerGlobal impression

VistaGen Therapeutics (VTGN) Reports Q1, Provides Corporate Update

VistaGen Therapeutics (VTGN) Reports Q1, Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMark mcpartlandShawn singhInternational number tollCompany quarterly report on formCompany phaseExchange commissionDrug administrationSubjective unitsDistress scaleChief executive officerClinical global impressions improvementGlobal impressionLiebowitz social anxiety scaleNew drug applicationFiscal year

Subsequent to the Release of Positive Phase 3 Trial Results, Vistagen Provides Corporate Update and Reports Fiscal 2024 First Quarter Financial Results

Positive top-line results from Phase 3 PALISADE-2 trial of rapid-onset fasedienol nasal spray in social anxiety disorder Itruvone nasal spray now staged for Phase 2B clinical development as a. -Today at 04:23 pm- MarketScreener

United statesShawn singhCompany quarterly report on formCompany phaseInternational number tollDrug administrationExchange commissionSubjective unitsDistress scaleChief executive officerClinical global impressions improvementGlobal impressionLiebowitz social anxiety scaleNew drug applicationFiscal yearQuarter financial